These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 14599178)

  • 1. Luotonin A. A naturally occurring human DNA topoisomerase I poison.
    Cagir A; Jones SH; Gao R; Eisenhauer BM; Hecht SM
    J Am Chem Soc; 2003 Nov; 125(45):13628-9. PubMed ID: 14599178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biochemical properties of E-ring modified luotonin A derivatives.
    Cagir A; Jones SH; Eisenhauer BM; Gao R; Hecht SM
    Bioorg Med Chem Lett; 2004 May; 14(9):2051-4. PubMed ID: 15080977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 14-azacamptothecin: a potent water-soluble topoisomerase I poison.
    Cheng K; Rahier NJ; Eisenhauer BM; Gao R; Thomas SJ; Hecht SM
    J Am Chem Soc; 2005 Jan; 127(3):838-9. PubMed ID: 15656613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and topoisomerase I inhibitory properties of luotonin A analogues.
    Cagir A; Eisenhauer BM; Gao R; Thomas SJ; Hecht SM
    Bioorg Med Chem; 2004 Dec; 12(23):6287-99. PubMed ID: 15519171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and topoisomerase poisoning activity of A-ring and E-ring substituted luotonin A derivatives.
    Nacro K; Zha CC; Guzzo PR; Jason Herr R; Peace D; Friedrich TD
    Bioorg Med Chem; 2007 Jun; 15(12):4237-46. PubMed ID: 17418582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and cytotoxic activity of substituted luotonin A derivatives.
    Dallavalle S; Merlini L; Beretta GL; Tinelli S; Zunino F
    Bioorg Med Chem Lett; 2004 Dec; 14(23):5757-61. PubMed ID: 15501036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regioselective quinazolinone-directed ortho lithiation of quinazolinoylquinoline: practical synthesis of naturally occurring human DNA topoisomerase I poison luotonin a and luotonins B and E.
    Mhaske SB; Argade NP
    J Org Chem; 2004 Jun; 69(13):4563-6. PubMed ID: 15202923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-pot synthesis of luotonin A and its analogues.
    Tseng MC; Chu YW; Tsai HP; Lin CM; Hwang J; Chu YH
    Org Lett; 2011 Mar; 13(5):920-3. PubMed ID: 21268635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA topoisomerase I inhibitory alkaloids from Corydalis saxicola.
    Cheng X; Wang D; Jiang L; Yang D
    Chem Biodivers; 2008 Jul; 5(7):1335-44. PubMed ID: 18649321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-Ring-Modified Analogues of Luotonin A with Reduced Planarity: Design, Synthesis, and Evaluation of Their Topoisomerase Inhibition-Associated Cytotoxicity.
    Almansour AI; Kumar RS; Arumugam N; Bianchini G; Menéndez JC; Mohammad F; Dupadahalli K; Altaf M
    Biomed Res Int; 2019; 2019():2514524. PubMed ID: 31815127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-ring-aryl substituted luotonin A analogues with a new binding mode to the topoisomerase 1-DNA complex show enhanced cytotoxic activity.
    González-Ruiz V; Pascua I; Fernández-Marcelo T; Ribelles P; Bianchini G; Sridharan V; Iniesta P; Ramos MT; Olives AI; Martín MA; Menéndez JC
    PLoS One; 2014; 9(5):e95998. PubMed ID: 24830682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of topoisomerase II-mediated DNA cleavage by three DNA-intercalating plant alkaloids: cryptolepine, matadine, and serpentine.
    Dassonneville L; Bonjean K; De Pauw-Gillet MC; Colson P; Houssier C; Quetin-Leclercq J; Angenot L; Bailly C
    Biochemistry; 1999 Jun; 38(24):7719-26. PubMed ID: 10387011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Water-soluble camptothecin derivatives that are intrinsic topoisomerase I poisons.
    Rahier NJ; Eisenhauer BM; Gao R; Jones SH; Hecht SM
    Org Lett; 2004 Feb; 6(3):321-4. PubMed ID: 14748583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel poly(ADP-Ribose) polymerase inhibitor, AG14361, sensitizes cells to topoisomerase I poisons by increasing the persistence of DNA strand breaks.
    Smith LM; Willmore E; Austin CA; Curtin NJ
    Clin Cancer Res; 2005 Dec; 11(23):8449-57. PubMed ID: 16322308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Camptothecin: current perspectives.
    Thomas CJ; Rahier NJ; Hecht SM
    Bioorg Med Chem; 2004 Apr; 12(7):1585-604. PubMed ID: 15028252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of camptothecin analog-topoisomerase I-DNA ternary complexes: a molecular dynamics study.
    Siu FM; Che CM
    J Am Chem Soc; 2008 Dec; 130(52):17928-37. PubMed ID: 19035632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of camptothecin derivatives on topoisomerase I-mediated DNA structure modification.
    Wang X; Wang LK; Kingsbury WD; Johnson RK; Hecht SM
    Biochemistry; 1998 Jun; 37(26):9399-408. PubMed ID: 9649322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: can we improve it?
    Jung LL; Zamboni WC
    Drug Resist Updat; 2001 Aug; 4(4):273-88. PubMed ID: 11998845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of DNA topoisomerase I and II isolated from the Coptis rhizomes.
    Kobayashi Y; Yamashita Y; Fujii N; Takaboshi K; Kawakami T; Kawamura M; Mizukami T; Nakano H
    Planta Med; 1995 Oct; 61(5):414-8. PubMed ID: 7480201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic compounds from Annonaceus species as DNA topoisomerase I poisons.
    López-Lázaro M; Martín-Cordero C; Bermejo A; Cortes D; Ayuso MJ
    Anticancer Res; 2001; 21(5):3493-7. PubMed ID: 11848514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.